摘要
为探究苍牛防己黄芪汤联合西医疗法对乙肝肝硬化腹水患者的临床疗效,本研究以2016年5~10月期间我院收治的64例乙肝肝硬化腹水患者为研究对象,随机分成两组,每组32例,对照组使用常规西医疗法,治疗组在西医疗法的基础上再配合苍牛防己黄芪汤治疗。观察并比较两组患者连续治疗1个月后的中医症候疗效、腹水复发率临床疗效差异。结果显示,治疗组的中医症候积分均明显低于对照组,治疗组的中医症候疗效和临床综合疗效明显优于对照组,治疗组的腹水复发率明显低于对照组。这表明,苍牛防己黄芪汤辅助西医基础治疗可有效改善乙肝肝硬化腹水患者中医症候症状,提升治疗效果,降低治疗后腹水复发率,为乙肝肝硬化腹水患者临床治疗提供参考。
To evaluate the clinical efficacy of western medicine plus Cangniufangjihuangqi decoction towards Hepatitis B Virus (HBV) cirrhosis ascites, 64 patients with HBV cirrhosis ascites in our hospital adopted from May to June in 2016 were elected and randomly divided into two groups. The treatment group of 32 cases was given conventional western medicine plus Cangniufangjihuangqi decoction, while the control group of 32 cases was given conventional western medicine. The TCM syndrome and the recurrence rate of ascites in two groups were observed and compared after treatment for a month. The results showed that the scores of TCM syndrome in treatment group was significantly lower than those of the control group, and the efficacy in treatment group was much better than that of the control group. The recurrence rate ofascites in treatment group was significantly lower than that of the control group. These proved that western medicine plus Cangniufangjihuangqi decoction could effectively improve the traditional Chinese medicine symptoms of HBV cirrhosis ascites patients, enhance the treatment effect and reduce the recurrence rate of ascites after treatment. This study could provid a reference for the therapy of Hepatitis B virus cirrhosis ascites.
出处
《基因组学与应用生物学》
CAS
CSCD
北大核心
2017年第6期2343-2348,共6页
Genomics and Applied Biology
基金
重庆市自然科学基金(21201402048)资助
关键词
苍牛防己黄芪汤
乙肝肝硬化腹水
临床疗效
Cangniufangjihuangqi decoction, Hepatitis B virus cirrhosis ascites, Clinical effect